EUDA Health Holdings Limited

NASDAQ:EUDA

Medical - Care Facilities

Healthcare
$17.70 +14.19%

+$2.20 today

Market cap
$53.00M
Beta
0.59
P/E (TTM)
-7.9
EPS (TTM)
-$1.79
52W Low $5.26High $71.20

Volume 0.04M

Average 0.02M

EUDA Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

EUDA Health Holdings LimitedNASDAQ: EUDA

Cost of Revenue · Q2 FY2026 · quarter ended Jun 2026

Cost of revenue dips below year-ago levels

Q2 FY2026 cost of revenue of $1.09M fell 1.6% year over year, behind the +70.2% change in trailing-twelve-month cost of revenue. Sequentially, it rose 0.0% from the prior quarter. Over 3 fiscal years it compounded at +9.8% a year.

Context

  • Cost of revenue amounted to 56.1% of revenue in FY2025, down 24.9 pp from a year earlier.
  • Cost of revenue increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -1.6% toward the trailing-twelve-month pace of +70.2%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$1.09M+0.0% QoQ
Last fiscal yearDec 2025
$3.83M+17.8% YoY
LTMJun 2026
$6.82M+70.2% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-1.6%——
1 year+17.8%——
3-year CAGR+9.8%——
5-year CAGR——
10-year CAGR——

Cost of Revenue history

USD · from the income statement

Latest · FY2025
3.83M USD
Year-over-year change
+17.8%
4-year CAGR
+3.7%

Cost of Revenue vs competitors

How EUDA compares with its peers on the latest reported figures

  • Peers report in different currencies, so cost of revenue is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +70.2% is the 3rd highest of 7, against a peer median of +11.2%.
  • Cost of revenue amounts to 56.0% of revenue for EUDA, versus a peer median of 55.0%.
EUDA Competitors
Cost of Revenue for EUDA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
AMWLAmerican Well CorporationLTM Mar 2026$119.38M USD-18.1%-10.1%50.3%
FONRFONAR CorporationLTM Mar 2026$62.93M USD+3.9%+6.7%59.7%
ATYRaTyr Pharma, Inc.LTM Mar 2026$22.52M USD+84.2%-2.9%11854.7%
HYPRHyperfine, Inc.LTM Mar 2026$7.48M USD+18.5%+4.9%48.8%
EUDAEUDA Health Holdings LimitedLTM Jun 2026$6.82M USD+70.2%+9.8%56.0%
ZTEKZentek Ltd.LTM Mar 2026CA$4.36M CAD+545.4%+96.4%2622.4%
DTILPrecision BioSciences, Inc.LTM Mar 2026$1.37M USD——3.0%
GUTSFractyl Health, Inc. Common StockLTM Mar 2026$0 USD-100.0%——
Peer median (excluding EUDA) —+11.2%+4.9%55.0%

Competitors are the stored peer set for EUDA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue4.56M3.76M3.71M4.01M6.82M
Cost of Revenue3.31M2.89M2.86M3.25M3.83M
Gross Profit1.25M870K842.08K762.16K2.99M
Gross Margin27.4%23.1%22.7%19.0%43.9%
Research & Development129.27K17.21K00249
Selling, General & Admin1.81M6.75M4.8M3.34M5.43M
Operating Expenses1.81M13.09M4.8M18.1M5.43M
Depreciation & Amortization264.1K172.02K119.35K173.22K406.48K
EBITDA1.34M(24.64M)(8.29M)(17.42M)(2.09M)
EBITDA Margin29.4%-654.6%-223.7%-434.4%-30.7%
Operating Income(559.99K)(5.72M)(3.96M)(17.34M)(2.44M)
Operating Margin-12.3%-151.9%-106.9%-432.2%-35.8%
Interest Income1.92M0000
Interest Expense127.13K93.78K23.23K44.89K228.62K
Other Income / Expenses2.23M(19.21M)(4.47M)(307.38K)(285.26K)
Income Before Tax1.67M(24.93M)(8.43M)(17.64M)(2.73M)
Pre-Tax Margin36.6%-662.3%-227.6%-439.8%-40.0%
Income Tax Expense46.49K(20.79K)0(4.38K)41.94K
Net Income864.83K(24.88M)(10.04M)(15.36M)(2.77M)
Net Margin19.0%-661.1%-270.9%-382.9%-40.7%
EPS (Basic)1.87(41.40)(8.80)(9.40)(1.49)
EPS (Diluted)1.87(41.40)(8.80)(9.40)(1.49)
Weighted Avg Shares462.67K601.48K1.15M1.62M1.86M
Weighted Avg Shares (Diluted)462.67K601.48K1.15M1.62M1.86M

EUDA Health Holdings Limited

NASDAQ:EUDA

Intrinsic Alpha fair value

Locked

Current Price

$17.70

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.